Is ovulation induction with letrozole in breast cancer patients still safe even if it could increase progesterone levels?

Del Pup, L; Peccatori, F A

Del Pup, L; Peccatori, F A.

Affiliation

Del Pup L; Gynecological Oncology, National Cancer Institute, Aviano (PN), Italy. ldelpup@cro.it.

Eur Rev Med Pharmacol Sci ; 22(1): 246-249, 2018 01.

Article in En | MEDLINE | ID: mdl-29364493

Subject(s)

Breast Neoplasms/pathology; Letrozole/therapeutic use; Ovulation Induction; Progesterone/analysis; Case-Control Studies; Female; Follicle Stimulating Hormone/therapeutic use; Gonadotropin-Releasing Hormone/agonists; Humans; Luteal Phase; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovulation Induction / Progesterone / Breast Neoplasms / Letrozole Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2018 Document type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google